• Publications
  • Influence
Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission.
OBJECTIVE To assess whether radiologic progression occurs during clinical remission in patients with rheumatoid arthritis (RA). METHODS One hundred eighty-seven patients with RA in clinicalExpand
  • 394
  • 10
Burden of caregiving: evidence of objective burden, subjective burden, and quality of life impacts on informal caregivers of patients with rheumatoid arthritis.
OBJECTIVE To improve understanding of the nature and magnitude of the burden of informal care and also to indicate important areas for improving the current ways in which informal care isExpand
  • 149
  • 8
A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis.
OBJECTIVE Chemokines such as CCL2/monocyte chemotactic protein 1 (MCP-1) play a key role in leukocyte migration and are potential targets in the treatment of chronic inflammatory disorders. TheExpand
  • 218
  • 6
Dimension-specific burden of caregiving among partners of rheumatoid arthritis patients.
OBJECTIVES To assess subjective caregiver burden among partners of rheumatoid arthritis (RA) patients and to identify partner and patient variables and objective caregiver burden related toExpand
  • 78
  • 6
  • PDF
Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis
Objectives To evaluate the efficacy and safety of adalimumab in patients with peripheral spondyloarthritis (SpA) not fulfilling the criteria for ankylosing spondylitis (AS) or psoriatic arthritisExpand
  • 54
  • 2
  • PDF
Alefacept therapy reduces the effector T-cell population in lesional psoriatic epidermis
Alefacept, a LFA-3/IgG1 fusion protein, interferes with the activation and proliferation of T cells by binding to the CD2 receptor on their surfaces. The clinical efficacy of this drug has beenExpand
  • 28
  • 2
  • PDF
The Features of the Synovium in Early Rheumatoid Arthritis According to the 2010 ACR/EULAR Classification Criteria
Objectives It has been shown in early arthritis cohorts that the 2010 ACR/EULAR criteria for rheumatoid arthritis (RA) enable an earlier diagnosis, perhaps at the cost of a somewhat moreExpand
  • 22
  • 2
  • PDF
CD20 antigen imaging with 124I-rituximab PET/CT in patients with rheumatoid arthritis
Introduction: Visualization of the CD20-antigen expression could provide a tool to localize sites of inflammation and could be of additive value in the diagnosis, and subsequently, in the treatmentExpand
  • 26
Rheumatologists' performance in daily practice
Objective. To assess rheumatologists’ performance for 8 rheumatologic conditions and to explore possible explanatory factors. Methods. After written informed consent was obtained, 27 rheumatologistsExpand
  • 19
The pharmacokinetics of 124I-rituximab in patients with rheumatoid arthritis
Rheumatoid arthritis is a destructive inflammatory joint disorder. Pre- and mature B-cells, characterized by CD20 antigen expression, play an important role in the inflammatory process. Rituximab, aExpand
  • 4